Company news

Guizhou Sanli Pharmaceutical Co., Ltd. Class A (SSE:603439) news

Guizhou Sanli Pharmaceutical Co., Ltd. Class A news releases on 6ix. Latest, Sep 15, 2026: "GUIZHOU SANLI PHARMACEUTICAL CO., LTD."Announcement on Abnormal…

View Guizhou Sanli Pharmaceutical Co., Ltd. Class A →

Press releases & updates

"GUIZHOU SANLI PHARMACEUTICAL CO., LTD."Announcement on Abnormal Fluctuations in Stock Trading

September 14, 2026

"GUIZHOU SANLI PHARMACEUTICAL CO., LTD."Semi-annual Report for 2026

August 27, 2026

"GUIZHOU SANLI PHARMACEUTICAL CO., LTD."Announcement on Reply to the Shanghai Stock Exchange's Information Disclosure Supervisory Inquiry Letter on the Company's 2025 Annual Report

July 23, 2026

"GUIZHOU SANLI PHARMACEUTICAL CO., LTD."Announcement on Implementation of Repurchase and Cancellation of Restricted Shares under the Equity Incentive Plan

July 21, 2026

"GUIZHOU SANLI PHARMACEUTICAL CO., LTD."Announcement on Expected Decrease in Semi-annual Performance for 2026

July 14, 2026

"GUIZHOU SANLI PHARMACEUTICAL CO., LTD."Announcement on Pledging Partial Shares of Person Acting in Concert of Controlling Shareholder

July 2, 2026

Announcement on Implementation of Dividend Distribution for 2025

June 23, 2026

Announcement on Progress in Drug Marketing Authorization Transfer

June 8, 2026

Announcement on Resolutions of the 24th Meeting of the 4th Board of Directors

May 25, 2026

Announcement on Resolutions of the 2025 Annual General Meeting

May 20, 2026

Announcement on the Holding of 2026 Collective Reception Day Activities for Investors of Listed Companies in Guizhou Jurisdiction and Outline of the 2025 Annual Performance Briefing

May 12, 2026

Announcement on Attending the 2026 Collective Reception Day for Investors of Listed Companies in Guizhou Jurisdiction and 2025 Annual Performance Briefing and Soliciting Questions

April 27, 2026

Announcement on Daily Related Party Transactions in 2025 and Estimates Daily Related Party Transactions in 2026

April 26, 2026

Announcement on Signing the "Agreement on Transfer of Drug Marketing Authorization Holder"

April 1, 2026

Announcement on Repurchasing and Canceling Some Restricted Stocks to Decrease Capital and Notice to Creditors

March 9, 2026

Announcement on Expected Decrease in Performance for 2025

January 23, 2026

Announcement on Resolutions of the 21st Meeting of the 4th Board of Directors

January 8, 2026

Announcement on Resolutions of the 20th Meeting of the 4th Board of Directors

December 25, 2025

Announcement on Signing of Technology Transfer Agreement with Hainan University

December 22, 2025

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025

December 18, 2025

Announcement on Implementing Change of the Stock Abbreviation

December 8, 2025

Announcement on the Wholly-owned Subsidiary’s Exit from a Joint Investment Enterprise with a Related Party and Termination of the Related Party Transaction

December 2, 2025

Notice on Convening the 1st Extraordinary General Meeting in 2025

November 27, 2025

Indicative Announcement on Execution of an Acting-in-Concert Agreement by the Controlling Shareholder and Resulting Change in Interests

November 7, 2025

Announcement on Resolutions of the 15th Meeting of the 4th Board of Supervisors

October 27, 2025

Announcement on Implementation of Repurchase and Cancellation of Equity Incentive Restricted Stocks

October 23, 2025

Announcement on Release of Pledge and Re-pledge of Partial Shares of Controlling Shareholders

October 21, 2025

Announcement on Expiration of Shareholding Reduction Plan for Shareholders and Results of Shareholding Reduction

October 9, 2025

Indicative Announcement on Equity Change Resulting from Shareholding Reduction of Shareholders with Over 5% Shares to Less than 5%

September 26, 2025

Announcement on Implementation Result of Shares Repurchase and Share Changes

September 12, 2025

Announcement on Progress in Repurchasing Shares

September 1, 2025

Announcement on Resolutions of the 15th Meeting of the 4th Board of Directors

August 27, 2025

Announcement on Resolutions of the 14th Meeting of the 4th Board of Directors

July 30, 2025

Announcement on Early Termination of Shareholding Reduction Plan for Some Directors and Senior Management Members and Results of Shareholding Reduction

July 11, 2025

Announcement on Completion of Implementing Share Reduction Plan for Partial Senior Management Members and Results of Share Reduction

July 10, 2025

Announcement on Completion of Implementing Share Reduction Plan for Certain Directors and Senior Management Members and Results of Share Reduction

July 8, 2025

Announcement on Departure of Senior Management Member

July 7, 2025

Announcement on Implementation of Dividend Distribution for 2024

June 19, 2025

Announcement on Resolution of the 13th Meeting of the 4th Board of Directors

June 12, 2025

Announcement on Plan of Share Reduction by Shareholder with Over 5% Shares, Directors and Senior Executives

June 11, 2025

Announcement on Resolution of the 2024 Annual General Meeting

May 16, 2025

Announcement on the Holding of 2025 Collective Reception Day for Investors of Listed Companies in Guizhou Jurisdiction and 2024 Annual Performance Briefing

May 13, 2025

Announcement on Attending the 2025 Investor Collective Meeting and 2024 Annual Performance Briefing of Listed Companies in Guizhou Jurisdiction and Soliciting Questions

April 25, 2025

Announcement on the Company's and Its Holding Subsidiary's Application for Comprehensive Credit Lines from Banks in 2025

April 22, 2025